New aspects on the metabolic role of intestinal microbiota in the development of atherosclerosis

Metabolism: Clinical and Experimental

Volumn 64, Issue 4, 2015, Pages 476-481

  Drosos, Ioannis ^a   Tavridou, Anna ^a   Kolios, George ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Atherosclerosis; Coronary artery disease; Gut; Intestinal; Microbiota

Indexed keywords

BETAINE; CARNITINE; CHOLINE; PHOSPHATIDYLCHOLINE; TRIMETHYLAMINE OXIDE; METHYLAMINE; TRIMETHYLOXAMINE;

ARTICLE; ATHEROSCLEROSIS; HUMAN; HYPERLIPIDEMIA; INTESTINE FLORA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RISK FACTOR; ANIMAL; INTESTINE; METABOLISM; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY;

ANIMALS; ATHEROSCLEROSIS; BETAINE; CARNITINE; CHOLINE; HUMANS; INTESTINES; METHYLAMINES; MICROBIOTA; PHOSPHATIDYLCHOLINES;

EID: 84923700244     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2015.01.007     Document Type: Review

References (57)

1. F. Backhed, R.E. Ley, J.L. Sonnenburg, D.A. Peterson, and J.I. Gordon Host-bacterial mutualism in the human intestine Science 307 5717 2005 1915 1920
2. F. Guarner, and J.R. Malagelada Gut flora in health and disease Lancet 361 9356 2003 512 519
3. C. Manichanh, N. Borruel, F. Casellas, and F. Guarner The gut microbiota in IBD Nat Rev Gastroenterol Hepatol 9 10 2012 599 608
4. K. Shimizu, H. Ogura, T. Asahara, K. Nomoto, M. Morotomi, and O. Tasaki Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective Dig Dis Sci 58 1 2013 23 32
5. The top 10 causes of death [cited 2014 January 12]; Available from: http://who.int/mediacentre/factsheets/fs310/en/
6. P. Saikku, M. Leinonen, L. Tenkanen, E. Linnanmaki, M.R. Ekman, and V. Manninen Chronic chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study Ann Intern Med 116 4 1992 273 278
7. S.J. Ott, N.E. El Mokhtari, M. Musfeldt, S. Hellmig, S. Freitag, and A. Rehman Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease Circulation 113 7 2006 929 937
8. J. Bartova, P. Sommerova, Y. Lyuya-Mi, J. Mysak, and J. Prochazkova Periodontitis as a risk factor of atherosclerosis 2014 2014 636893
9. P.A. Van Leeuwen, M.A. Boermeester, A.P. Houdijk, C.C. Ferwerda, M.A. Cuesta, and S. Meyer Clinical significance of translocation Gut 35 1 Suppl. 1994 S28 S34
10. C.J. Wiedermann, S. Kiechl, S. Dunzendorfer, P. Schratzberger, G. Egger, and F. Oberhollenzer Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study J Am Coll Cardiol 34 7 1999 1975 1981
11. V. Dinakaran, A. Rathinavel, M. Pushpanathan, R. Sivakumar, P. Gunasekaran, and J. Rajendhran Elevated levels of circulating DNA in cardiovascular disease patients: metagenomic profiling of microbiome in the circulation PLoS One 9 8 2014 e105221
12. J. Frohlich, and A. Al-Sarraf Cardiovascular risk and atherosclerosis prevention Cardiovasc Pathol 22 1 2013 16 18
13. J.S. Park, J.H. Seo, and H.S. Youn Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease Pediatr Gastroenterol Hepatol Nutr 16 1 2013 22 27
14. L. Conterno, F. Fava, R. Viola, and K.M. Tuohy Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr 6 3 2011 241 260
15. V. Tremaroli, and F. Backhed Functional interactions between the gut microbiota and host metabolism Nature 489 7415 2012 242 249
16. M.K. Piya, P.G. McTernan, and S. Kumar Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin J Endocrinol 216 1 2013 T1 T15
17. H. Tilg, and A.R. Moschen Microbiota and diabetes: an evolving relationship Gut 63 9 2014 1513 1521
18. R.E. Ley, P.J. Turnbaugh, S. Klein, and J.I. Gordon Microbial ecology: human gut microbes associated with obesity Nature 444 7122 2006 1022 1023
19. P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, and J.I. Gordon An obesity-associated gut microbiome with increased capacity for energy harvest Nature 444 7122 2006 1027 1031
20. F. Backhed, H. Ding, T. Wang, L.V. Hooper, G.Y. Koh, and A. Nagy The gut microbiota as an environmental factor that regulates fat storage Proc Natl Acad Sci U S A 101 44 2004 15718 15723
21. R.E. Ley, F. Backhed, P. Turnbaugh, C.A. Lozupone, R.D. Knight, and J.I. Gordon Obesity alters gut microbial ecology Proc Natl Acad Sci U S A 102 31 2005 11070 11075
22. P.B. Eckburg, E.M. Bik, C.N. Bernstein, E. Purdom, L. Dethlefsen, and M. Sargent Diversity of the human intestinal microbial flora Science 308 5728 2005 1635 1638
23. F. Fava, R. Gitau, B.A. Griffin, G.R. Gibson, K.M. Tuohy, and J.A. Lovegrove The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome 'at-risk' population Int J Obes (Lond) 37 2 2013 216 223
24. H. Kumar, R. Lund, A. Laiho, K. Lundelin, R.E. Ley, and E. Isolauri Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis MBio 5 6 2014
25. S.H. Duncan, G.E. Lobley, G. Holtrop, J. Ince, A.M. Johnstone, and P. Louis Human colonic microbiota associated with diet, obesity and weight loss Int J Obes (Lond) 32 11 2008 1720 1724
26. M. Vijay-Kumar, J.D. Aitken, F.A. Carvalho, T.C. Cullender, S. Mwangi, and S. Srinivasan Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 Science 328 5975 2010 228 231
27. N. Larsen, F.K. Vogensen, F.W. van den Berg, D.S. Nielsen, A.S. Andreasen, and B.K. Pedersen Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults PLoS One 5 2 2010 e9085
28. E. Le Chatelier, T. Nielsen, J. Qin, E. Prifti, F. Hildebrand, and G. Falony Richness of human gut microbiome correlates with metabolic markers Nature 500 7464 2013 541 546
29. J.F. Brugere, G. Borrel, N. Gaci, W. Tottey, P.W. O'Toole, and C. Malpuech-Brugere Archaebiotics: proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease Gut Microbes 5 1 2014 5 10
30. J.R. Ussher, G.D. Lopaschuk, and A. Arduini Gut microbiota metabolism of l-carnitine and cardiovascular risk Atherosclerosis 231 2 2013 456 461
31. R.M. LeLeiko, C.S. Vaccari, S. Sola, N. Merchant, S.H. Nagamia, and M. Thoenes Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome Am J Cardiol 104 5 2009 638 643
32. O. Danne, C. Lueders, C. Storm, U. Frei, and M. Mockel Whole blood choline and plasma choline in acute coronary syndromes: prognostic and pathophysiological implications Clin Chim Acta 383 1-2 2007 103 109
33. F.S. Apple, A.H. Wu, J. Mair, J. Ravkilde, M. Panteghini, and J. Tate Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome Clin Chem 51 5 2005 810 824
34. J.D. Spence, D.J. Jenkins, and J. Davignon Egg yolk consumption and carotid plaque Atherosclerosis 224 2 2012 469 473
35. Z. Wang, W.H. Tang, J.A. Buffa, X. Fu, E.B. Britt, and R.A. Koeth Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide Eur Heart J 35 14 2014 904 910
36. Z. Wang, E. Klipfell, B.J. Bennett, R. Koeth, B.S. Levison, and B. Dugar Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease Nature 472 7341 2011 57 63
37. W.H. Tang, Z. Wang, B.S. Levison, R.A. Koeth, E.B. Britt, and X. Fu Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk N Engl J Med 368 17 2013 1575 1584
38. S.C. Mitchell, A.Q. Zhang, J.M. Noblet, S. Gillespie, N. Jones, and R.L. Smith Metabolic disposition of [14C]-trimethylamine N-oxide in rat: variation with dose and route of administration Xenobiotica 27 11 1997 1187 1197
39. D. Tsikas, T. Thum, T. Becker, V.V. Pham, K. Chobanyan, and A. Mitschke Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography-mass spectrometry as pentafluorobenzamide derivative: evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease J Chromatogr B Analyt Technol Biomed Life Sci 851 1-2 2007 229 239
40. J.C. Martin, C. Canlet, B. Delplanque, G. Agnani, D. Lairon, and G. Gottardi 1H NMR metabonomics can differentiate the early atherogenic effect of dairy products in hyperlipidemic hamsters Atherosclerosis 206 1 2009 127 133
41. G.D. Lewis, R. Wei, E. Liu, E. Yang, X. Shi, and M. Martinovic Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury J Clin Invest 118 10 2008 3503 3512
42. R.A. Koeth, Z. Wang, B.S. Levison, J.A. Buffa, E. Org, and B.T. Sheehy Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis Nat Med 19 5 2013 576 585
43. J.J. DiNicolantonio, C.J. Lavie, H. Fares, A.R. Menezes, and J.H. O'Keefe l-Carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis Mayo Clin Proc 88 6 2013 544 551
44. T.L. Broderick, H.A. Quinney, C.C. Barker, and G.D. Lopaschuk Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation Circulation 87 3 1993 972 981
45. R.C. Noland, T.R. Koves, S.E. Seiler, H. Lum, R.M. Lust, and O. Ilkayeva Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control J Biol Chem 284 34 2009 22840 22852
46. D.M. Muoio, R.C. Noland, J.P. Kovalik, S.E. Seiler, M.N. Davies, and K.L. DeBalsi Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility Cell Metab 15 5 2012 764 777
47. A.M. Johri, D.K. Heyland, M.F. Hetu, B. Crawford, and J.D. Spence Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: Evidence and controversies Nutr Metab Cardiovasc Dis 24 8 2014 808 814
48. F.H. Karlsson, F. Fak, I. Nookaew, V. Tremaroli, B. Fagerberg, and D. Petranovic Symptomatic atherosclerosis is associated with an altered gut metagenome Nat Commun 3 2012 1245
49. O. Koren, A. Spor, J. Felin, F. Fak, J. Stombaugh, and V. Tremaroli Human oral, gut, and plaque microbiota in patients with atherosclerosis Proc Natl Acad Sci U S A 108 Suppl. 1 2011 4592 4598
50. F.P. Martin, Y. Wang, N. Sprenger, I.K. Yap, T. Lundstedt, and P. Lek Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model Mol Syst Biol 4 2008 157
51. A.R. Moschen, V. Wieser, and H. Tilg Dietary Factors: Major Regulators of the Gut's Microbiota Gut Liver 6 4 2012 411 416
52. J. Stock Gut microbiota: an environmental risk factor for cardiovascular disease Atherosclerosis 229 2 2013 440 442
53. J.R. Cashman, Y. Xiong, J. Lin, H. Verhagen, G. van Poppel, and P.J. van Bladeren In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles Biochem Pharmacol 58 6 1999 1047 1055
54. J. Matal, J. Orsag, J. Nekvindova, E. Anzenbacherova, A. Veinlichova, and P. Anzenbacher Experimental approaches to studies on drug metabolism and drug interactions in man: interaction of acyclic nucleoside phosphonates with human liver cytochromes P450 and flavin-containing monooxygenase 3 Neuro Endocrinol Lett 27 Suppl. 2 2006 27 30
55. I.M. Hisamuddin, and V.W. Yang Genetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectives Pharmacogenomics 8 6 2007 635 643
56. J. Hartiala, B.J. Bennett, W.H. Tang, Z. Wang, A.F. Stewart, and R. Roberts Comparative genome-wide association studies in mice and humans for trimethylamine N-oxide, a proatherogenic metabolite of choline and l-carnitine Arterioscler Thromb Vasc Biol 34 6 2014 1307 1313
57. J. Kuka, E. Liepinsh, M. Makrecka-Kuka, J. Liepins, H. Cirule, and D. Gustina Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting l-carnitine microbial degradation Life Sci 117 2 2014 84 92